BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luckhoff H, Phahladira L, Scheffler F, Asmal L, du Plessis S, Chiliza B, Kilian S, Emsley R. Weight gain and metabolic change as predictors of symptom improvement in first-episode schizophrenia spectrum disorder patients treated over 12 months. Schizophrenia Research 2019;206:171-6. [DOI: 10.1016/j.schres.2018.11.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Luckhoff HK, du Plessis S, Kilian S, Asmal L, Scheffler F, Phahladira L, Olivier RM, Emsley R. Hippocampal subfield volumes and change in body mass over 12 months of treatment in first-episode schizophrenia spectrum disorders. Psychiatry Res Neuroimaging 2020;300:111084. [PMID: 32388386 DOI: 10.1016/j.pscychresns.2020.111084] [Reference Citation Analysis]
2 Smit AM, Kilian S, Emsley RA, Luckhoff HK, Swartz L, Seedat S, Asmal L. Associations of premorbid adjustment with type and timing of childhood trauma in first-episode schizophrenia spectrum disorders. S Afr J Psychiatr 2021;27:1639. [PMID: 34230867 DOI: 10.4102/sajpsychiatry.v27i0.1639] [Reference Citation Analysis]
3 Zhou Y, Song X, Guo Y, Lang X, Li Z, Zhang XY. Sex differences in metabolic disorder patterns of first-episode drug-naive patients with schizophrenia. Psychoneuroendocrinology 2021;124:105061. [PMID: 33291004 DOI: 10.1016/j.psyneuen.2020.105061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Huang CF, Guo SE, Chou FH. Auricular acupressure for overweight and obese individuals: A systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e16144. [PMID: 31261540 DOI: 10.1097/MD.0000000000016144] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Meftah AM, Deckler E, Citrome L, Kantrowitz JT. New discoveries for an old drug: a review of recent olanzapine research. Postgraduate Medicine 2020;132:80-90. [DOI: 10.1080/00325481.2019.1701823] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
6 Esan O, Esan A. Body mass index (BMI) and obesity in Nigerians with schizophrenia. Nord J Psychiatry 2021;:1-6. [PMID: 34010092 DOI: 10.1080/08039488.2021.1926538] [Reference Citation Analysis]
7 Kumar S, Sudhakar S, Sajatovic M, Levin JB. Antipsychotic Medication in Sub-Saharan Africa: A Systematic Literature Review. J Clin Psychopharmacol 2020;40:541-52. [PMID: 33009226 DOI: 10.1097/JCP.0000000000001282] [Reference Citation Analysis]
8 Zhu Y, Centorrino F, Jackson JW, Fitzmaurice GM, Valeri L. Meta-analysis of Total Effect Decomposition in the Presence of Multiple Mediators: The Example of Schizophrenia Treatment. Epidemiology 2021;32:120-30. [PMID: 33181564 DOI: 10.1097/EDE.0000000000001269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Luckhoff HK, du Plessis S, Scheffler F, Phahladira L, Kilian S, Buckle C, Smit R, Chiliza B, Asmal L, Emsley R. Fronto-limbic white matter fractional anisotropy and body mass index in first-episode schizophrenia spectrum disorder patients compared to healthy controls. Psychiatry Res Neuroimaging 2020;305:111173. [PMID: 32896691 DOI: 10.1016/j.pscychresns.2020.111173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Lang X, Zhou Y, Zhao L, Gu Y, Wu X, Zhao Y, Li Z, Zhang X. Differences in patterns of metabolic abnormality and metabolic syndrome between early-onset and adult-onset first-episode drug-naive schizophrenia patients. Psychoneuroendocrinology 2021;132:105344. [PMID: 34274733 DOI: 10.1016/j.psyneuen.2021.105344] [Reference Citation Analysis]
11 Kim DD, Barr AM, Fredrikson DH, Honer WG, Procyshyn RM. Association between Serum Lipids and Antipsychotic Response in Schizophrenia. Curr Neuropharmacol 2019;17:852-60. [PMID: 30819084 DOI: 10.2174/1570159X17666190228113348] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
12 Albitar O, Harun SN, Ahmad SNA, Sheikh Ghadzi SM. A Repeated Time-to-Positive Symptoms Improvement among Malaysian Patients with Schizophrenia Spectrum Disorders Treated with Clozapine. Pharmaceutics 2021;13:1121. [PMID: 34452082 DOI: 10.3390/pharmaceutics13081121] [Reference Citation Analysis]